Neramexane

Source: Wikipedia, the free encyclopedia.
Neramexane
Clinical data
ATC code
  • none
Identifiers
  • 1,3,3,5,5-pentamethylcyclohexanamine
JSmol)
  • C1(C)(N)CC(C)(C)CC(C)(C)C1
  • InChI=1S/C11H23N/c1-9(2)6-10(3,4)8-11(5,12)7-9/h6-8,12H2,1-5H3 ☒N
  • Key:OGZQTTHDGQBLBT-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Neramexane is a drug related to

drug addiction[7] and as an analgesic.[8] Animal studies have also suggested antidepressant[9] and nootropic[10] actions, so there are a wide range of potential applications this drug may be used for. It also acts as a nicotinic acetylcholine receptor antagonist.[11]

A clinical trial found that doses of 50 mg and above safely improved tinnitus scores over 16 weeks.[12]

See also

References

  1. S2CID 8654883
    .
  2. .
  3. .
  4. ^ Clinical trial number NCT00405886 for "Neramexane for Tinnitus" at ClinicalTrials.gov
  5. ^ Clinical trial number NCT00739635 for "Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus" at ClinicalTrials.gov
  6. PMID 16523403
    .
  7. .
  8. .
  9. .
  10. .
  11. .
  12. .